Advertisement

Response letter to Shetty and Shetty’s reply about DRAIN trial

  • Simone FreaEmail author
  • Stefano Pidello
  • Serena Bergerone
  • Fabrizio D’Ascenzo
Letter to the Editors
  • 10 Downloads

Sirs:

In 1988, Serena Bergerone, MD, published one of the first studies on ultrafiltration in advanced heart failure patients [1]. After more than 30 years, we still discuss about optimal dosing and method of delivery of diuretics in patients with acute heart failure. After more than 500 publications about the use of furosemide in acute heart failure, a consensus is still lacking. In particular, the DOSE trial did not overcome all the gaps in evidence. Every physician committed to acute heart failure treatment could easily tell the reason. Acute heart failure is a manifold syndrome and patients admitted for acute heart failure should be thoroughly evaluated to tailor the best treatment. Response to diuretics may depend on many elements such as the degree of congestion (with particular attention to abdominal congestion [2] and dilutional hyponatremia [3]), the right ventricular function (with particular attention to right atrial pressure and tricuspid regurgitation [4]), the perfusion...

References

  1. 1.
    DiLeo M, Pacitti A, Bergerone S, Pozzi R, Tognarelli G, Segoloni G, Vercellone A, Brusca A (1988) Ultrafiltration in the treatment of refractory congestive heart failure. Clin Cardiol 11:449–452CrossRefGoogle Scholar
  2. 2.
    Frea S, Bovolo V, Pidello S, Canavosio FG, Botta M, Bergerone S, Gaita F (2015) Clinical and prognostic role of ammonia in advanced decompensated heart failure. The cardio-abdominal syndrome? Int J Cardiol 195:53–60CrossRefGoogle Scholar
  3. 3.
    Omar HR, Guglin M (2019) Higher diuretic requirements in acute heart failure with admission hyponatraemia versus normonatraemia. Heart Lung Circ.  https://doi.org/10.1016/j.hlc.2018.12.014 CrossRefPubMedGoogle Scholar
  4. 4.
    Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C, Piepoli MF, Crespo-Leiro MG, Lainscak M, Ponikowski P, Filippatos G, Ruschitzka F, Seferovic P, Coats AJS, Lund LH, ESC-EORP HFA Heart Failure Long-Term Registry Investigators (2019) Acute heart failure congestion and perfusion status—impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail 2019:24. [Epub ahead of print]Google Scholar
  5. 5.
    Frea S, Pidello S, Volpe A, Canavosio FG, Galluzzo A, Bovolo V, Camarda A, Golzio PG, D’Ascenzo F, Bergerone S, Rinaldi M, Gaita F (2019) Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial. Clin Res Cardiol 2019:29. [Epub ahead of print]Google Scholar
  6. 6.
    Cannon CP, Bhatt DL, Oldgren J, RE-DUAL PCI Steering Committee and Investigators et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377:1513–1524CrossRefGoogle Scholar
  7. 7.
    Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284–1293CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Divisions of CardiologyCittà della Salute e della Scienza University HospitalTurinItaly

Personalised recommendations